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Figure 1. Normal skin structure ( Terese Winslow)
?
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4. MERKEL CELL CARCINOMA
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4.1. ETIOLOGY
4.1.1. Ultraviolet radiation 
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4.1.3. Merkel cell polyomavirus
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4.2. MERKEL CELL CARCINOMA AND OTHER CANCERS 
)11+ !+-B&+&'&!-! , &5# +-&#+  '!




, &&'& , &!+!)11&! ##   '!+,+! (
2+-+ *
1& !#

















+& ' ,)11*"&+ !+ # !
 !+F&!-! ,1//




 - +  ,  !+!  , ++ '+-( +   & &+  +-
'++--(+-  -' #
& #+(#5




-#  '!5-++++*)  ,
&



















, # *   * M ( -5' D 	 -'  * "& +

 C
++ , &!+-!-!G-+' !+!!5+!+,








$ &C++,,!-B&)11*"&+  ,# B #+-,,

 (5# 5-
 )11 # ! ## #+	0'+*
?( -' (+&+*(0+*(E+ 5+*(
















































 B& ,+  -! &# 'J!+#
 # ,)11
	+&+**"&# ! ##  !+ , )11&&+-+-!
++	0 .++-++*(+&+*(0'+*?(,  B-
&C#*7+ !!+ !+ !!55
 !-++(5!&+
 +#5! + &'+++*
"&#+4   , 
+


















 + 5'  ,&
#+5# &+-!-	E5I5++*
(.++**
)11&++&'&-!,  !+!5!	DO(' +#
& -
#++	O(+--+#++	DO*









"&#-+#, +!5!# &	+'D# &FO ,&
!5! !!5B&+ ,-+' 	0+*()-++! 
+**

Figure 2. A rapidly grown Merkel cell carcinoma in the deltoid area of a 68-year old man. Two months 
earlier a small lump was excised at a primary health care center. The scar is visible in the middle of the 
tumor. The black spots are marks for sentinel node biopsy.
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Table 1. Differential diagnosis of Merkel cell carcinoma by immunohistochemistry (Modiﬁed from McKee 
et al. 2005b, Llombart et al. 2005, Hanly et al. 2000, Koljonen et al. 2005, Goessling et al. 2002, Poulsen 


















MCC 89-100 0 0 0 50-100 80 95 80-
100
100
SCLC 3-33 83-100 0 0 0 64
Lymph 0 98 6 0 11
SCM 0 0 0 97 0 71
BCC 0

Figure 3a. MCC in HE staining. Original magniﬁcation x200.
Figure 3b. Positive CK-20 staining. Original magniﬁcation x200.
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4.6. STAGING AND PROGNOSIS
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Table 2. Memorial Sloan-Kettering Cancer Center staging system (Allen et al. 2005)
Stage MCC 5-year disease speciﬁc survival (%)
I Local disease <2cm 81
II Local disease 2cm 67
III Regional nodal disease 52
IV Distant metastatic disease 11
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Table 3. American Joint Committee on Cancer consensus staging system for MCC (AJCC 2010)
Primary tumor (T)
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor (e.g. nodal/metastatic presentation without 
associated primary tumor)
Tis In situ primary tumor
T1 2 cm maximum tumor dimension
T2 >2 cm but 5 cm maximum tumor dimension
T3 >5 cm maximum tumor dimension
T4 Primary tumor invades bone, muscle, fascia or cartilage
Regional lymph nodes (N)
NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
cN0 Nodes negative in clinical examination (no histopathological examination 
performed)
pN0 Nodes negative by histopathological examination
N1 Metastasis in regional lymph node(s)
N1a Micrometastasis (diagnosed after sentinel or elective lymphadenectomy)
N1b Macrometastasis (clinically detectable nodal metastases conﬁrmed by CLND 
or needle biopsy)
N2 In transit metastasis
Distant metastases (M)
M0 No distant metastasis
M1 Metastasis beyond regional lymph nodes
M1a Metastasis to skin, subcutaneous tissues or distant lymph nodes
M1b Metastasis to lung
M1c Metastasis to all other visceral sites

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Anatomic stage / prognostic groups
Stage 0 Tis N0 M0
Stage IA T1 pN0 M0
Stage IB T1 cN0 M0
Stage IIA T2/T3 pN0 M0
Stage IIB T2/T3 cN0 M0
Stage IIC T4 N0 M0
Stage IIIA Any T N1a M0
Stage IIIB Any T N1b/N2 M0
Stage IV Any T Any N M1
4.7. TREATMENT 
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4.7.3. Distant metastatic disease (Stage IV)
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5.1. ANGIOGENESIS IN TUMOR GROWTH AND METASTASES
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5.1.1. Vascular endothelial growth factor
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5.1.2. Vascular endothelial growth factor receptors
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5.1.4. Anti-angiogenic therapy
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5.2. TUMOR LYMPHATIC VESSELS
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AIMS OF THE STUDY
: " C
 &








::: " C+#&!!+,+5 ,)!
  #+5+-)
 !!+! #+






++B +-, #&&1+!<' +!+B&+ + 
 ,)!!+! #+ #+!!+! #+ ,&-5'DF













, #B++5+-*"&-+'  ,)11B++--- &'
+*"&J-+'  ,)11+-B+#+-?*




+B&)11-5' D 	LB +!- +- ! !-( ,
+++*"& '+5+#
	 
(JC! (C!  #++
B++++, #?
+*"&-+' B! J#-+--,+& 
B  ,&+!&	"$+-3*
 & 
+&  '!+! J#+  ,&-+' (BI5-&+&5# 
# 
&  'B+! B&)11&&#+ C +-5
! (+-&+&B
 ##5 +', ! +	13
*:,13B+'+(5# 
&  '! B&)11(&-+' 
B+! J#-5'##5 +', +
 
&+-!& # '+0*










-#  '!!!+5-	.5-:+-BB-# 






##5 & !&#(5'+!5+- &+#+1?+-(
+-, )12	L5'
 #+!&++! 	1<+-I5++


















*) -+--++, !!+! 5+-+#B +-, #&
& 
+! -+-&+&!+!& 5'& 5&! 5*
"&##5#C! #+' 	##5#-+! ,&+& 5 , #
5#    ! #+'( & ++   -




:+ +C! - !+B&!&5# !+ -+&
! #+' &  '!+C+#+ ( &,#+'&+##(
   
B+
, #-*"&#+'+C! ' 5
!  ,!+ 




C!# +-5 )11(+-! #-+
!J!5+*:
B+!+!5+-, #&-+ ,&  '!+-+'  &-+ ,-+&  &
! '-+ ,&+++	!#?(*















head and neck 102 53.3
trunk 22 12.2
upper extremity 27 14.9
lower extremity 22 12.2
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Figure 4. Lymphovascular invasion. Staining with CD31 (a) and D2-40 (b). A cluster of tumor cells within 
a lymph vessel (L). Endothelial cells of an artery (A) stained with CD31, but remained negative with D2-
40 staining. Original magniﬁcation x200.

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Figure 5. Blood vascular invasion. Staining with CD31 (a), and D2-40 (b). A cluster of tumor cells within 
a blood vessel (B) identiﬁed by CD31 staining. The endothelial cells remained negative in D2-40 staining. 
Original magniﬁcation x200.
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Table 6. Clinical characteristics of Merkel cell carcinoma patients at diagnosis (Study II)







range 50–100  
 
Tumor location
head or neck 73 57.9
upper extremities 21 16.7
trunk 14 11.1






I Local only <2cm 75 59.5
II Local only 2cm 36 28.6
III Nodal* 11 8.7
IV Distant metastatic 4 3.2
*nodal disease assessed by palpation or histological evaluation (when performed)
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MERKEL CELL POLYOMA VIRUS (STUDY III)
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Table 7. Patient and tumor characteristics of 114 patients (Study III)
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Table 8. Patient and tumor characteristics of VEGFR-2 and the endostatin study (Studies IV-V)
VEGFR-2 study (n=21) Endostatin study (n=19)




median ( range) 78 (59–100) 78 (59–100)
Tumor size (cm)
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EPIDEMIOLOGICAL-CLINICAL STUDY (STUDY I)
INCIDENCE
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Table 9. Treatment of the primary lesion and subsequent recurrences in Merkel cell carcinoma patients 
presenting with clinically local disease (Stage I-II) with known primary tumor (n=155)




No. of patients (%)






Intralesional exc. 27 7 (26%) 6 (22%) 1 (4%) 14 (52%)
Intralesional exc.
+RT
6 0 2 (33%) 0 2 (33%)
Marginal exc. 81 10 (12%) 10 (12%) 8 (10%) 28 (35%)
Marginal exc. +RT 13 0 2 (15%) 2 (15%) 4 (31%)
Wide exc. 18 2 (11%) 4 (22%) 1 (6%) 7 (39%)
Wide Exc +RT 2 0 0 1 (50%) 1 (50%)
Unknown 7 2 (29%) 1 (14%) 0 3 (43%)
Unknown+RT 1 0 0 0 0
Total 155 21 (14%) 25 (16%) 13 (8%) 59 (38%)
exc. = excision
RT = radiotherapy





Local 35 59.3 3 (1-61)
In-transit 3 5.1 7 (4-34)
Regional lymph node 19 32.2 8 (2-56)
Distant 2 3.4 9 and 27

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Table 11. Five-year relative survival ratio (%) among 180* Merkel cell carcinoma patients, with 95% conﬁdence 
interval, by sex and stage (closing date Dec. 31, 2007).
Men Women All
Stage I 57.7 (30.5–85.6) 71.5 (55.0-–86.6) 68.7 (54.0–81.8)
Stage II 28.5 (7.0–60.4) 88.0 (56.7–114) 67.0 (44.3–88.6)
Stage III 0 28.7 (4.4–66.2) 16.5 (2.7–43.7)
Stage IV 0 0 0 
All 35.7 (20.3–53.5) 69.4 (56.0–81.9) 59.2 (49.0-70.0)
* One 100-year-old patient was dropped because the population life table did not go beyond the 
age of 99 years. 
(LYMPHO)VASCULAR INVASION IN MERKEL CELL CARCINOMA 
(STUDY II)
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Table 12. Development of regional or distant metastases in cases with only local disease at the time of 
diagnosis (N= 111)
LVI+, BVI+ LVI+, BVI- LVI-, BVI+ LVI-, BVI-
N= 26 N= 73 N= 3 N= 9
Regional lymph node 3 (11.5%) 14 (19.2%) 0 0
Regional and distant 2 (7.7%) 2 (2.7%) 0 0
Distant only 1 (3.8%) 3 (4.1%) 1 (33.3%) 0
Total 6/ 26 19/ 73 1/ 3 0/ 9
LVI + = lymphovascular invasion detected
LVI  = lymphovascular invasion not detected
BVI + = blood vascular invasion detected
BVI  = blood vascular invasion not detected
MERKEL CELL POLYOMA VIRUS (STUDY III)
0 + ,	*O ,&!+! #+'+-&+-)12=0(+-!-








 5# B-!-5'I5++1<! #
+-






#  ,&+)12=0'+!+!* B(&B+ -,,!
B)12
 +-'+!+! #+'+- C(#-++'
















Figure 6. Kaplan-Meier analysis of the survival of patients whose tumors contained (+) Merkel cell 
polyoma virus DNA or lacked it (-). 
 
A) Merkel cell carcinoma speciﬁc survival, B) overall survival
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VEGFR-2 AND ENDOSTATIN (STUDIES IV,V)
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Table 13. Staining intensity, tumor size and possible metastasis (++ strong, + low, - negative, 0 = sample 
not available)
Sample no. VEGFR-2 Endostatin Tumor size (cm) Metastasis
1 ++ - 3.0 no
2 + - 1.0 no
3 + + 1.0 no
4 - - 0.8 no
5 + 0 1.0 no
6 - + 1.0 no
7 + + 4.0 no
8 ++ + 1.4 no
9 - + 2.0 yes
10 + - 6.0 yes
11 + - 1.5 yes
12 + - 3.0 no
13 - - 1.2 no
14 + 0 4.0 yes
15 + - 2.0 no
16 ++ - 2.0 yes
17 ++ + 1.5 yes
18 ++ - 4.0 yes
19 ++ + 3.0 no
20 + + 1.5 yes
21 + - 3.0 no

DISCUSSION
EPIDEMIOLOGICAL-CLINICAL STUDY (STUDY I)
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(LYMPHO)VASCULAR INVASION IN MERKEL CELL CARCINOMA 
(STUDY II)
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MERKEL CELL POLYOMA VIRUS STUDY (STUDY III)
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